Fresenius Medical Care, which largely provides kidney dialysis services, confirmed in a January news release that it sold National Cardiovascular Partners and its 21 cardiac catheterization and vascular labs.
The divestiture was driven by “exiting unsustainable markets and non-core businesses,” as well as an effort to “enable more focused capital allocation towards areas in our core business that are expected to have higher profitable growth,” Fresenius said in its fourth-quarter financial report filed with the SEC, which was posted Feb. 21.
The group is now listed as part of SCA Health on the company’s website.
SCA Health also acquired Pivotal Healthcare in July 2023, according to Pitchbook. The Ponte Vedra Beach, Fla.-based cardiovascular care platform has 11 affiliate practices and 14 locations, according to the company’s website.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.